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Time-resolved magnetic resonance angiography as
a noninvasive method to characterize endoleaks:
Initial results compared with conventional
angiography
Robert A. Lookstein, MD,a Jeffrey Goldman, MD,b Lev Pukin, MD,a and Michael L. Marin, MD,c New
York, NY
Purpose: Several types of endoleaks have been described, each with different methods of treatment. Conventional
arteriography is widely regarded as the gold standard for the classification of endoleaks. Recently, faster magnetic
resonance gradients have allowed for rapid data acquisition and review of vascular studies as a real-time continuous
angiogram (time resolved magnetic resonance angiography [TR-MRA]). This study was performed to compare the
findings of TR-MRA with conventional angiography for the characterization of endoleaks.
Methods: Between June 2002 and June 2003, 12 patients with documented endoleaks following endovascular repair of
aortic aneurysms (10 abdominal and two thoracic) underwent TR-MRA to identify and characterize the endoleak. All
patients had nitinol-based aortic stent grafts. MRA was performed on a 1.5-Tesla magnet (Sonata class; Siemens Medical
Systems, Iselin, NJ). The TR-MRA studies were reviewed under continuous observation as a “cine MR angiogram.”
These MRA data sets were used to classify the endoleaks into types 1 through 3. The patients underwent conventional
angiography following the MRA to confirm the findings and to plan treatment. The MRA findings were compared with
the findings made at conventional arteriography.
Results: TR-MRA identified seven patients with type 1 leaks, including four proximal and three distal. Four patients had
type 2 leaks, including two arising from the inferior mesenteric artery and two from an iliolumbar artery. One patient had
a type 3 leak. Conventional angiography confirmed the type of endoleak in all 12 patients.
Conclusion: These initial results demonstrate TR-MRA to be an effective noninvasive method for classifying endoleaks.
This technique may allow for screening of patients with endoleaks to identify those requiring urgent repair. (J Vasc Surg
2004;39:27-33.)
Since being first described over a decade ago, the
endovascular repair of aortic aneurysms has emerged as an
attractive alternative to traditional open repair.1 The cur-
rent enthusiasm for the endovascular technique has been
tempered by the relatively high incidence of complications
following the procedure.2 The most common complication
reported following endovascular aneurysm repair has been
endoleak, or persistent perfusion of the aneurysm sac.3
Four different types of endoleaks have been previously
described. Each of these types has distinct implications for
the aneurysm repair, with different influence on the growth
of the aneurysm sac as well as risk of aneurysm rupture.4-6
Recently, several authors have reported a preference for
urgent treatment of attachment site (type 1) leaks and
fabric tear or modular component separation (type 3) leaks
and a conservative observation of retrograde side branch
(type 2) leaks.7-9 As a result of this difference in treatment
for different types of endoleaks, it has become crucial to
identify the type of endoleak occurring in each patient
during follow-up.
At present, the overwhelming majority of patients who
have undergone endovascular aneurysm repair are followed
up with computed tomographic angiography (CTA). Al-
though numerous reports have described the high sensitiv-
ity and specificity of CTA in identifying endoleaks, no study
has addressed its accuracy in characterizing an endoleak as a
specific type.10 At present, conventional digital subtraction
angiography is regarded as the gold standard for character-
izing endoleaks.11 Magnetic resonance angiography
(MRA) has been previously reported as an acceptable im-
aging modality for the follow-up of patients who have
undergone endovascular aneurysm repair, with excellent
sensitivity and specificity in the diagnosis of endoleaks when
compared with CTA.12,13
Contrast-enhanced time-resolved MRA (TR-MRA) is a
technique first described in 1996 as a method to observe
changes in direction of vascular flow over time during a MR
imaging examination.14-17 With the use of faster gradients,
TR-MRA can currently be performed with subsecond ac-
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quisitions.18 The resulting dynamic MRA, consisting of
dozens of acquisitions obtained in a single breath-hold, can
be viewed as a continuous loop similar to a conventional
flush aortogram. To date, no report has studied the ability
of TR-MRA to characterize endoleaks.
The purpose of this study is to describe the initial use of
TR-MRA in the characterization of endoleaks and to com-
pare those results with conventional digital subtraction
angiography.
MATERIAL AND METHODS
The TR-MRA technique, which was developed and
evaluated with a protocol approved by the Mount Sinai
Medical Center institutional review board, was subse-
quently incorporated into routine clinical practice.
All patients in this study received treatment as part of a
single-institution sponsor-investigator investigational de-
vice exemption study for the endovascular repair of aortic
aneurysms in patients at high risk for open surgical repair.
The institutional review board approved the protocol
for endovascular repair of patients with aortic aneurysms,
including procedural technique and follow-up. All patients
gave informed consent.
Between June 2002 and June 2003, 12 patients with
endoleaks documented on previous CT angiograms follow-
ing endovascular repair with nitinol based devices (Talent;
Medtronic, Minneapolis, Minn), including 10 patients
with aortoiliac devices and two patients with thoracic de-
vices, were referred for MRA before conventional angiog-
raphy in an attempt to characterize the endoleak into types
1 through 4. All 12 patients were scheduled for conven-
tional angiography because of enlarging aneurysm diameter
during follow-up.
MRA. All studies were performed with a 1.5-Tesla
MR system (Magnetom Sonata; Siemens Medical Systems,
Iselin, NJ). Initial-survey MR images of the entire area of
interest were acquired in all patients with one-heartbeat
non–breath-hold true fast imaging with steady-state pre-
cession (FISP) imaging (3.2/1.6 repetition time [millisec-
ond/echo time millisecond]) in the sagittal, coronal, and
axial planes. This was performed to localize the stent graft.
Localization was followed by a timing bolus of 3 cc of
gadopentate dimeglumine, which was observed at the level
of the celiac axis. This was followed by conventional three-
dimensional (3D) MRA of the anatomic area of interest.
Conventional 3D MRA was performed by injecting 30 mL
of gadopentate dimeglumine at a rate of 5 cc/sec. This was
immediately followed by the injection of 20 mL of saline at
5 cc/sec. Breath holding and the start of the data acquisi-
tion was timed to coincide with the arrival of the contrast-
material bolus. The final sequence for the conventional 3D
MRA was an axial fat saturation T1 weighted sequence
(FLASH).
The conventional 3D MRA was then reviewed to diag-
nose the extent of the endoleak cavity, including location
within the aneurysm sac as well as the involvement of any
branch vessels. During the review, a protocol for the TR-
MRA was formed to include the entire stent graft and the
endoleak cavity, including involved side branches.
TR-MRA. The technique for this imaging has been
previously described.19 Our institutional technique is sum-
marized in Table I.20 The protocol included the injection
of 20 cc gadopentate dimeglumine at a rate of 5 cc/sec
followed by 20 cc saline at a rate of 5 cc/sec. Patients were
instructed to hold their breath, and imaging acquisition in
the coronal plane was started simultaneously with the in-
jection of contrast material. Measurements were repeated at
intervals of 0.6-2 sec for a total of 40 sec. The TR data set
was then reconstructed using 3D online digital subtraction
techniques. This 3D data set was used to create a “cine
loop,” which was reviewed as a contrast-enhanced 3D MR
flush aortogram to characterize the direction of flow in the
endoleak channel and aortic side branches if patent.
Digital subtraction angiography. Following MRA
examination all patients were referred for conventional
digital subtraction angiography to classify the endoleak.
The time interval from MRA to conventional angiography
ranged from 1 to 58 days, with a mean of 16 and a median
of 8 days. All conventional angiography was performed in a
dedicated peripheral angiography suite using a Phillips
INTEGRIS system. (Phillips Medical Systems, Andover,
MA).
Angiography was performed using standard Seldinger
technique from a femoral approach. Flush aortography was
performed through 5-French calibrated marker catheters to
identify the source of the endoleak. The catheter was ini-
Table I. Mount Sinai magnetic resonance angiography (MRA) technique for endoleak characterization
Parameter TruFisp
Time-resolved
MRA
Conventional
three-
dimensional
MRA FLASH
Repetition time (msec) 3.17 2.1 2.96 188
Echo time (msec) 1.59 0.91 1.13 2.48
Flip angle (degrees) 19 25
Partition thickness (mm) 16 2.0
Matrix size 320  207 256  230
Pixel size (mm2) 1.5  1.3  16 1.4  1.3  2.0
Bandwidth (Hz/pixel) 1420 500
Imaging time for each data set (sec) 0.6–2.0 15
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tially placed at the level of the renal arteries, and aortogra-
phy was performed in the anteroposterior and lateral pro-
jections. All flush injections were performed with ioversol
(Mallinckrodt Inc, St. Louis, MO), 320 mg iodine per
milliliter at a rate of 15 cc/sec for 2 sec. The catheter was
then retracted into the stent graft device, and repeat flush
angiography was performed. If no endoleak was seen, a
selective superior mesenteric artery injection was per-
formed as well as a selective hypogastric artery injection to
exclude a type 2 leak.
In the patients with the thoracic device, a 5-French
calibrated marker catheter was placed in the ascending
aortic arch, and a flush arch aortogram was performed in
left anterior oblique and lateral projections. The catheter
was then retracted into the device, and flush aortography
was performed of the descending thoracic aorta in antero-
posterior and lateral projections.
Image analysis. The TR-MRA data sets were re-
viewed before conventional angiography by both an inter-
ventional radiologist and a vascular surgeon. These results
were prospectively recorded and were compared with the
results of the conventional angiogram. An independent
interventional radiologist and vascular surgeon reviewed
the angiogram during the examination to categorize the
endoleak into type 1, 2, 3, or 4.
Definitions. The classification of endoleaks for this
study was in accordance with the standards of the Ad Hoc
Committee for Standardized Reporting Practices in Vascu-
lar Surgery of The Society for Vascular Surgery/American
Association for Vascular Surgery.21
RESULTS
All patients underwent successful MRA as well as con-
ventional angiography. There were no complications re-
lated to either procedure. Of the 10 patients with abdom-
inal endografts, nine were bifurcated devices, and one was
an aortouniiliac device. The aortic lumen as well as the
aneurysm sac could be visualized in the nine patients with
bifurcated devices. The patient with the aortouniiliac device
had significant metallic artifact over the caudal aspect of the
aneurysm and the distal attachment site as a result of the
stainless steel embolization coils used to occlude the con-
tralateral common iliac artery. This artifact did not obscure
the visualization of the proximal attachment site and the
proximal type 1 leak in this patient. In all 10 patients the
endoleak channel could be visualized and characterized
with TR-MRA.
In the two patients with the thoracic devices, there was
excellent visualization of the aneurysm sac, endograft, and
endoleak channel. In all 12 patients, the postprocedure CT
angiogram had characterized the endoleak as type 2, thus
placing all patients in follow-up for monitoring for aneu-
rysm enlargement. This characterization was incorrect in 8
of the 12 patients in this series. Our series demonstrated 7
type 1 leaks, 4 type 2 leaks, and 1 type 3 leak. There was
100% concordance between the results obtained from the
TR-MRA and those obtained from the conventional angio-
gram (Fig. 1). The results of the endoleak characterization
are summarized in Table II.
DISCUSSION
This initial feasibility study demonstrates the strength
of TR-MRA for the follow-up of patients following endo-
vascular aneurysm repair as compared with CTA. The in-
herent problem with CTA for follow-up is that the en-
doleak is characterized on the basis of a static temporal
image from the CT angiogram. Some imaging characteris-
tics are specific for certain types of endoleaks, but many are
not specific. In particular, enhancement of aortic side
branches can be an imaging characteristic of all types of
endoleaks, depending on the direction of flow in the vessel.
Types 1, 3, and 4 will have antegrade flow in the aortic side
branches, whereas type 2 leaks will have retrograde flow in
at least one aortic side branch. Many centers are currently
using 3D reconstructions of CT datasets from commercial
workstations or programs. Although this technology is
extremely useful for detecting endoleaks and aneurysm
expansion in the follow-up of patients, it is a static temporal
data set that cannot visualize direction of flow. This limita-
tion in CT angiography technology resulted in several
patients at our institution with type 1 or type 3 leaks that
were misdiagnosed as type 2 leaks. Our data demonstrate
this limitation, in that all of the patients studied in this series
were characterized as having type 2 leaks and were placed
into follow-up. Several patients in fact had type 1 or 3 leaks.
These patients had aneurysms that were not excluded and
were at significant risk for expansion and rupture.
The inherent limitation of CT angiography has led
many investigators to examine the role of duplex ultra-
sound for the follow-up of these patients. Previous reports
have demonstrated excellent preliminary results in the abil-
ity of ultrasound to identify and characterize en-
doleaks.22,23 No study to date has prospectively compared
the results of duplex ultrasound with conventional angiog-
raphy in the characterization of endoleaks.
Magnetic resonance angiography has been shown to be
an excellent alternative to CTA for the follow-up of these
patients. Several reports have shown MRA to be as sensitive
as CTA for the detection of endoleaks.12 One report has
shown MRA to be more sensitive than CTA for the detec-
tion of type 2 leaks.13 We have found similar results at our
institution and have begun using MRA liberally to follow
up patients with renal insufficiency.
One limitation of MRA is its somewhat limited appli-
cability to only those patients with nitinol-based supported
or unsupported devices. Patients with stainless steel devices
are unable to be followed with MRA because of the signif-
icant metallic artifact caused by the stainless steel compo-
nents. Similarly, patients who have undergone emboliza-
tion procedures with stainless steel coils are unable to be
followed with MRA because of the artifact from the coils.24
This artifact was present for the visualization of the iliac
arteries for one of the patients in this study. Platinum
embolization coils, in contrast, are nearly invisible for MRI
and create no artifact. At present, at our institution we are
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Fig 1. A, Multidetector computed tomographic angiogram of a patient with a bifurcated aortic stent graft and a large
endoleak seen to the left side of the graft. Shaded surface display and maximum intensity projection demonstrate the endoleak
to be in continuity with the inferior mesenteric artery. The leak is in proximity to the proximal attachment site of the device.
B, Contrast-enhanced magnetic resonance angiography in anteroposterior and lateral projections demonstrate the endoleak
channel.
JOURNAL OF VASCULAR SURGERY
January 200430 Lookstein et al
only placing nitinol-based supported devices and have
switched to using platinum coils for all embolization pro-
cedures. This allows any patient treated at our institution to
undergo MRA examination if necessary.
TR-MRA has been described previously as an effective
imaging technique to assess congenital cardiac anomalies,
pulmonary perfusion abnormalities including congenital
arteriovenous fistulae, and the circulation to the peripheral
vasculature.13-15 To our knowledge, this study is the first
description of this MRA technique in the characterization
of endoleaks and the first study to compare this technique
to conventional angiography.
Previously, at our institution patients had a flush aor-
togram performed in the operating suite at the completion
of the stent-graft implantation. If no type 1 or type 3
endoleak was seen, the procedure was completed. The
patient was then scheduled for follow-up CT angiography
within the first month and then at 6 months, 12 months,
and annually. Any endoleak detected at follow-up was
characterized by the CT angiogram. All type 1 and type 3
endoleaks were scheduled for conventional angiography.
Any patient with a type 2 leak was observed unless the
aneurysm sac was shown to have expanded by 5 mm or
more in diameter.
The results of this study brought about a change in the
way that our endovascular aneurysm repair patients are
followed (Fig. 2). At present, the intraoperative evaluation
is unchanged. The patient is then referred for CTA during
the first month following the procedure. If no endoleak is
present, the patient returns at 6 months and then at 12
months to monitor the aneurysm diameter. If an endoleak
is present, the patient returns at 3 months to see whether
the endoleak is still present. If it is still present, the CT is
reviewed by an interventional radiologist as well as a vascu-
lar surgeon to attempt to characterize the endoleak. Type 1
and type 3 leaks are referred for conventional angiography
to plan treatment. Type 2 leaks are monitored with CTA
every 3 months to monitor for aneurysm expansion. Any
patient with an endoleak that cannot be uniformly classified
on the basis of CTA is sent for TR-MRA examination to
characterize the endoleak and treat the patient accordingly.
Table II. Results of time-resolved magnetic resonance
angiography versus conventional angiography
Patient
Computed
tomographic
angiography
Time-resolved
magnetic
resonance
angiography
Conventional
angiogram
Abdominal
1 Type 2 Type 1-Proximal Type 1-Proximal
2 Type 2 Type 1-Distal Type 1-Distal
3 Type 2 Type 2-IMA Type 2-IMA
4 Type 2 Type 1-Proximal Type 1-Proximal
5 Type 2 Type 2-Lumbar Type 2 Lumbar
6 Type 2 Type 1-Proximal Type 1-Proximal
7 Type 2 Type 3 Type 3
8 Type 2 Type 1-Distal Type 1-Distal
9 Type 2 Type 2-IMA Type 2-IMA
10 Type 2 Type 2-Lumbar Type 2-Lumbar
Thoracic
1 Type 2 Type 1-Distal Type 1-Distal
2 Type 2 Type 1-Proximal Type 1-Proximal
IMA, Inferior mesenteric artery.
Fig 1 (continued). C, Time-resolved magnetic resonance angiography imaged in the coronal plane demonstrates that
this patient with a bifurcated abdominal endograft has a proximal type 1 endoleak with outflow via the inferior
mesenteric artery. D, Conventional digital subtraction angiogram confirms the diagnosis of the proximal type.
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Because both the interventional radiology department and
the vascular surgery department believe in the usefulness of
this diagnostic modality, there exists a low threshold to
refer a patient with an endoleak for a TR-MRA examina-
tion. This allows our patients to avoid an invasive angio-
gram simply to diagnose the more common type 2 en-
doleak that is currently treated conservatively at our
institution.
As endovascular technology is used more and more
frequently to treat patients with aneurysms, there will be an
increasing number of patients who have endoleak as a
complication. This initial study demonstrates that TR-
MRA can visualize the direction of flow in an endoleak
cavity. TR-MRA allows for a noninvasive method to char-
acterize the endoleak and prescribe the appropriate treat-
ment. Further studies will be required to further define the
exact role of TR-MRA for all patients with aortic en-
dografts.
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